PharmaShots

MAY 19, 2023

Alimera Acquires Rights from EyePoint Pharmaceuticals to Commercialise Yutiq in the US Date: May 19, 2023 | Tags: Alimera, EyePoint Pharmaceuticals, Yutiq, Iluvien, chronic non-infectious uveitis, US, Pharma Sobi Reports EMA’s Validation of MAA for Efanesoctocog Alfa to Treat Haemophilia A Date: May 19, 2023 | Tags: Sobi, Efanesoctocog Alfa, (..)

Medical Schools 40

Medical Schools Biosimilars Immunity Immunization 40

PharmaShots

FEBRUARY 3, 2023

4D Molecular Therapeutics Receives the US FDA’s IND Clearance of 4D-150 for the Treatment of Diabetic Macular Edema Date: Feb 03, 2023 | Tags: 4D Molecular Therapeutics, 4D-150, Diabetic Macular Edema, Regulatory, US, FDA, IND AstraZeneca and Amgen Receive the US FDA’s Approval of Tezspire (tezepelumab) for the Treatment of Severe Asthma (..)

Biosimilars 40

Biosimilars Diabetes Labelling 40

Fuld & Company Blog

MARCH 27, 2023

Wegovy goes mainstream By December 2020, Novo had further developed its move into the weight loss market when it received approval for its recombinant GLP-1, Saxenda , approved for chronic weight management, but this only provided marginal weight loss in trial. Wegovy’s weekly maintenance dose is 2.4 mg, while Ozempic’s is only 0.5

Diabetes 52

Diabetes Online Pharmacies Packaging Pharmaceutical Companies 52

RX Note

FEBRUARY 9, 2024

Abscess 脓肿 - A painful collection of pus under the skin or within the body. Analgesia 镇痛 - The removal of pain while a patient is conscious. Angina pectoris 心绞痛 - Chest pain. Arthralgia 关节痛 - Joint pain. Bunion 拇囊炎 - Painful bony bump that develops on the inside of the foot at the big toe joint.

Immunity 40

Immunity Immunization Diabetes Communication 40